Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Scientists Discover That Eating Peanuts Every Day May Help Protect the Aging Brain (opens in a new tab)

scitechdaily.com · 2026-10-27

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

2 claims go further than the study. 3 other points were not covered by the paper.

  • 1 supported
  • 2 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

Two of six claims overstate the study. One of six checks out. Three claims the study doesn't address.

  • 1 supported
  • 2 overstated
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6OverstatedA daily serving of peanuts may improve insulin sensitivity in the aging brain, potentially supporting memory.View evidenceHide evidence

Why this verdict

The abstract-level profile supports a randomized crossover trial finding an altered regional cerebral-blood-flow response to intranasal insulin after 60 g/day peanut intake, in a cluster overlapping some memory-related regions. But the headline frames this as peanuts improving brain insulin sensitivity and potentially supporting memory. That goes beyond the abstract profile’s more limited evidence: a single right-hemisphere cluster with reduced CBF response, probabilistic atlas localization, and no current-trial cognitive outcome reported in the abstract. The headline also generalizes to the “aging brain” and memory support more broadly than the measured endpoint.

1

Study evidence

A single right‑hemisphere brain region showed reduced cerebral blood flow response to intranasal insulin after 16 weeks of daily unsalted, skin‑roasted peanut intake versus the no‑peanut control in a randomized crossover sample of older adults.-5.4 ± 5.4 mL per 100 g tissue per min (mean difference); cluster size 552 mm3; P = 0.044

“In a randomized, single-blind, controlled crossover study, 31 older adults (67 ± 4 years) consumed either 60 g day-1 of unsalted, skin-roasted peanuts or followed a no-peanut control period for 16 weeks, separated by an 8-week washout.”
Claim 2 of 6OverstatedIn a small clinical trial, researchers at Maastricht University Medical Center found that eating unsalted, skin-roasted peanuts daily for 16 weeks improved insulin responsiveness in brain regions involved in memory.View evidenceHide evidence

Why this verdict

The trial design, intervention duration, and regional brain-insulin-responsiveness endpoint are supported. However, the story states unhedged that peanuts “improved insulin responsiveness” in memory brain regions. The abstract profile describes a single cluster with reduced CBF response to intranasal insulin and atlas-probability overlap with regions including hippocampus and parahippocampal gyrus; it is more cautious to describe this as altered regional brain insulin responsiveness rather than a clearly demonstrated improvement across memory regions.

1

Study evidence

A single right‑hemisphere brain region showed reduced cerebral blood flow response to intranasal insulin after 16 weeks of daily unsalted, skin‑roasted peanut intake versus the no‑peanut control in a randomized crossover sample of older adults.-5.4 ± 5.4 mL per 100 g tissue per min (mean difference); cluster size 552 mm3; P = 0.044

“In a randomized, single-blind, controlled crossover study, 31 older adults (67 ± 4 years) consumed either 60 g day-1 of unsalted, skin-roasted peanuts or followed a no-peanut control period for 16 weeks, separated by an 8-week washout.”
Claim 3 of 6Not coveredThe trial included 31 healthy adults aged 60 to 75 in a randomized, controlled crossover design.View evidenceHide evidence

As stated31 healthy adults aged 60 to 75; 16 weeks

Why this verdict

The abstract profile supports N=31 older adults in a randomized, single-blind, controlled crossover trial lasting 16-week periods. It reports mean age 67 ± 4 years, but the exact age range 60 to 75 and the characterization as healthy adults are not available in the supplied abstract-depth profile.

1

Study evidence

A single right‑hemisphere brain region showed reduced cerebral blood flow response to intranasal insulin after 16 weeks of daily unsalted, skin‑roasted peanut intake versus the no‑peanut control in a randomized crossover sample of older adults.-5.4 ± 5.4 mL per 100 g tissue per min (mean difference); cluster size 552 mm3; P = 0.044

“In a randomized, single-blind, controlled crossover study, 31 older adults (67 ± 4 years) consumed either 60 g day-1 of unsalted, skin-roasted peanuts or followed a no-peanut control period for 16 weeks, separated by an 8-week washout.”
Claim 4 of 6Not coveredEarlier results from the same 16-week peanut intervention, published in 2025 in Clinical Nutrition, showed a 3.6% increase in global cerebral blood flow and a 5.8% improvement in verbal memory.View evidenceHide evidence

As stated3.6% increase in global cerebral blood flow; 5.8% improvement in verbal memory

Why this verdict

The abstract profile notes only that previous work reported improved memory with daily unsalted, skin-roasted peanut intake. It does not provide the cited Clinical Nutrition publication details, the 3.6% global cerebral blood flow increase, or the 5.8% verbal-memory improvement. These numerical prior-study claims cannot be verified from the supplied abstract-depth profile.

1

Study evidence

A single right‑hemisphere brain region showed reduced cerebral blood flow response to intranasal insulin after 16 weeks of daily unsalted, skin‑roasted peanut intake versus the no‑peanut control in a randomized crossover sample of older adults.-5.4 ± 5.4 mL per 100 g tissue per min (mean difference); cluster size 552 mm3; P = 0.044

“In a randomized, single-blind, controlled crossover study, 31 older adults (67 ± 4 years) consumed either 60 g day-1 of unsalted, skin-roasted peanuts or followed a no-peanut control period for 16 weeks, separated by an 8-week washout.”
Claim 5 of 6Not coveredThe study also assessed cognitive performance with CANTAB and liver fat with abdominal MRI.View evidenceHide evidence

Why this verdict

The abstract profile supports assessment of intrahepatic lipid content using abdominal MRI. It does not mention CANTAB or current-study cognitive-performance testing, so the full combined claim cannot be verified at abstract depth.

1

Study evidence

Intrahepatic lipid (IHL) content measured by abdominal MRI was reported as unchanged after 16 weeks of daily 60 g peanut consumption compared with the control period in this randomized crossover sample (N=31).

“Intrahepatic lipid (IHL) content was quantified using abdominal MRI.”
Claim 6 of 6SupportedDuring the peanut period, participants ate 60 grams daily, about two servings, of unsalted, skin-roasted peanuts.View evidenceHide evidence

As stated60 grams daily

Why this verdict

The abstract profile states that participants consumed 60 g/day of unsalted, skin-roasted peanuts for 16 weeks during the peanut period. The “about two servings” conversion is not specifically evidenced in the profile, but the core intervention amount and peanut type are supported.

1

Study evidence

A single right‑hemisphere brain region showed reduced cerebral blood flow response to intranasal insulin after 16 weeks of daily unsalted, skin‑roasted peanut intake versus the no‑peanut control in a randomized crossover sample of older adults.-5.4 ± 5.4 mL per 100 g tissue per min (mean difference); cluster size 552 mm3; P = 0.044

“In a randomized, single-blind, controlled crossover study, 31 older adults (67 ± 4 years) consumed either 60 g day-1 of unsalted, skin-roasted peanuts or followed a no-peanut control period for 16 weeks, separated by an 8-week washout.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Brain insulin responsiveness was operationalized as the cerebral-blood-flow response to intranasal insulin measured with ASL-MRI.

    The story discusses insulin responsiveness but does not clearly convey the operational measurement: CBF response after intranasal insulin using ASL-MRI. This matters because the endpoint is a neuroimaging challenge response, not a direct clinical measure of brain insulin sensitivity.

    From randomized single‑blind controlled crossover trial

  • The main positive neuroimaging result was limited to one right-hemisphere voxelwise cluster with reduced CBF response after peanut intake versus control; localization to memory-related areas was probabilistic, with hippocampus and parahippocampal gyrus probabilities of 14% and 11%.

    The story frames the finding as improved responsiveness in memory regions, but the abstract profile describes a single cluster, reduced CBF response, cluster-level inference, and probabilistic atlas localization. Omitting these details makes the result appear broader and more definitive than the abstract-level evidence supports.

    From randomized single‑blind controlled crossover trial

  • Intrahepatic lipid content measured by abdominal MRI remained unchanged after peanut intake compared with control.

    The story says liver fat was assessed, but it does not reflect the paper’s reported null result for intrahepatic lipid content.

    From randomized single‑blind controlled crossover

  • Fasting circulating markers of glucose homeostasis, lipid metabolism, and low-grade systemic inflammation remained unchanged.

    The abstract profile presents these unchanged biomarker results as secondary outcomes. The story’s presented claims and caveats do not mention these null peripheral biomarker findings.

    From randomized single‑blind controlled crossover

3 things the story did carry across
  • The paper’s primary evidence is a randomized, single-blind, controlled crossover trial in 31 older adults comparing 16 weeks of 60 g/day unsalted, skin-roasted peanuts with a no-peanut control period, separated by an 8-week washout.
  • The study has a modest sample size of 31 participants.
  • The paper profile notes prior work reporting improved memory with daily unsalted, skin-roasted peanut intake, but the supplied abstract-depth evidence does not provide the specific prior-study CBF and verbal-memory percentages.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoTest whether 16 weeks of daily unsalted, skin-roasted peanut consumption alters brain insulin responsiveness in older adults, assessed via CBF response to intranasal insulin using ASL-MRI, compared with a no-peanut control period in a randomized crossover trial.randomized single‑blind controlled crossover trialExpand

In plain English

Randomized, single-blind, controlled crossover trial in 31 older adults testing whether 16 weeks of daily unsalted, skin‑roasted peanut consumption (60 g/day) alters brain insulin responsiveness. Brain insulin responsiveness was measured as changes in cerebral blood flow (CBF) following intranasal insulin using arterial spin labeling MRI (ASL-MRI). Whole-brain analysis identified one right-hemisphere cluster with reduced CBF response after the peanut period versus control (mean difference -5.4 ± 5.4 mL per 100 g tissue per min; cluster size 552 mm3; P = 0.044). Intrahepatic lipid content and circulating markers of glucose homeostasis, lipid metabolism, and low-grade systemic inflammation were unchanged.

Key findings

  • A single right‑hemisphere brain region showed reduced cerebral blood flow response to intranasal insulin after 16 weeks of daily unsalted, skin‑roasted peanut intake versus the no‑peanut control in a randomized crossover sample of older adults.-5.4 ± 5.4 mL per 100 g tissue per min (mean difference); cluster size 552 mm3; P = 0.044
  • Intrahepatic lipid content and circulating fasting markers of glucose homeostasis, lipid metabolism, and low‑grade systemic inflammation did not change between the peanut and control periods.
“In a randomized, single-blind, controlled crossover study, 31 older adults (67 ± 4 years) consumed either 60 g day-1 of unsalted, skin-roasted peanuts or followed a no-peanut control period for 16 weeks, separated by an 8-week washout.”
What this piece can’t prove
  • Modest sample size (N = 31) reported.
  • Abstract does not provide full statistical model details, correction for multiple comparisons, or precise intranasal insulin dosing/timing parameters.

2 further details could not be confirmed from the summary.

2human in vivoAssess whether the peanut intervention changes intrahepatic lipid (IHL) content measured by abdominal MRI.randomized single‑blind controlled crossoverExpand

In plain English

In a randomized, single-blind, controlled crossover trial of 31 older adults, intrahepatic lipid (IHL) content quantified by abdominal MRI was reported as unchanged after 16 weeks of daily consumption of 60 g unsalted, skin‑roasted peanuts compared with a no‑peanut control period (8‑week washout between periods).

Key findings

  • Intrahepatic lipid (IHL) content measured by abdominal MRI was reported as unchanged after 16 weeks of daily 60 g peanut consumption compared with the control period in this randomized crossover sample (N=31).
“Intrahepatic lipid (IHL) content was quantified using abdominal MRI.”
What this piece can’t prove
  • Abstract lacks methodological detail for the abdominal MRI protocol and IHL quantification (no sequences, analysis pipeline, or ROI/voxel‑based vs. spectroscopy details).
  • Relatively small sample size (N=31) may limit sensitivity to detect modest changes in hepatic fat.

1 further detail could not be confirmed from the summary.

3human in vivoAssess whether the peanut intervention changes fasting circulating markers of glucose homeostasis, lipid metabolism, and low-grade systemic inflammation.randomized single‑blind controlled crossoverExpand

In plain English

In a randomized, single-blind, controlled crossover trial of 31 older adults, fasting venous blood samples assayed for markers of glucose homeostasis, lipid metabolism, and low-grade systemic inflammation showed no change after 16 weeks of daily consumption of 60 g unsalted, skin‑roasted peanuts compared with a no‑peanut control period.

Key findings

  • Fasting circulating markers of glucose homeostasis, lipid metabolism, and low‑grade systemic inflammation were reported as unchanged after 16 weeks of daily 60 g peanut intake compared with the control period.
“Fasting blood samples were evaluated for markers of glucose homeostasis, lipid metabolism, and low-grade systemic inflammation.”
What this piece can’t prove
  • Modest sample size (N=31) may limit precision; abstract does not report power or sample size justification for these outcomes.
  • Abstract does not describe statistical methods used to analyze crossover biomarker data or assessment of potential carryover effects.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 37 candidate papers

Candidate

Fibril Synthesis From Food Processing By‐Products and Strategies for Structure–Function Stabilization for Food Applications

Sustainable Food Proteins · 2026 · Crossref

Source (opens in a new tab)

And 31 more candidates considered.